(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 0.47% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.22%.
Rxsight's revenue in 2025 is $148,310,000.On average, 13 Wall Street analysts forecast RXST's revenue for 2025 to be $5,201,533,568, with the lowest RXST revenue forecast at $4,978,030,173, and the highest RXST revenue forecast at $5,393,340,118. On average, 13 Wall Street analysts forecast RXST's revenue for 2026 to be $5,550,605,235, with the lowest RXST revenue forecast at $4,886,596,965, and the highest RXST revenue forecast at $6,080,511,467.
In 2027, RXST is forecast to generate $6,162,191,799 in revenue, with the lowest revenue forecast at $5,336,448,345 and the highest revenue forecast at $7,185,430,980.